An Intraoperative Telemedicine Program to Improve Perioperative Quality Measures: The ACTFAST-3 Randomized Clinical Trial
Authors' conclusion
In this randomized clinical trial, anesthesia care quality measures did not differ between groups, with high confidence in the findings.
Study context
- Population
- Adult surgical patients at a large academic medical center in the US, 2017–2019
- Participants
- 26,254 patients
- Comparison
- Intervention vs Control
- Interventionn = 13,274
- Controln = 12,980reference
- Primary endpoint
- Avoidance of postoperative hypothermia (final intraoperative core temperature >36 °C) and hyperglycemia (patients with diabetes with blood glucose ≤180 mg/dL on arrival to the postanesthesia recovery area)
Methodological detailssingle-centre, pilot
- Single-centre
- Pilot
Secondary outcomes
| Outcome | RR (95% CI) | |
|---|---|---|
| Intraoperative glucose measurement in patients with diabetes | 1.07 (1.01–1.15) | |
| 0.512Relative risk (log scale) |
Other secondary outcomes (intraoperative hypotension, temperature monitoring, antibiotic redosing, NMB documentation, ventilator management, volatile anesthetic overuse)
- Not significantly different
Original publication
An Intraoperative Telemedicine Program to Improve Perioperative Quality Measures: The ACTFAST-3 Randomized Clinical Trial. JAMA Netw Open. Published 5 September 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →